Share of people with HIV who receive antiretroviral therapy in Estonia
Estonia: Share of people with HIV who receive antiretroviral therapy was 69.0% in 2022. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Estonia, 2000–2022
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
In 2022, share of people with hiv who receive antiretroviral therapy in Estonia stood at 69.0%.
Compared with earlier readings it is down 1.4% on the previous year and up 53.3% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Estonia peaked at 72.0% in 2019 and was at its lowest, 2.0%, in 2002.
That places Estonia 78th out of 143 countries with data for 2022, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Estonia, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 13.0% | — |
| 2001 | 3.0% | -76.9% |
| 2002 | 2.0% | -33.3% |
| 2003 | 2.0% | +0.0% |
| 2004 | 3.0% | +50.0% |
| 2005 | 7.0% | +133.3% |
| 2006 | 11.0% | +57.1% |
| 2007 | 16.0% | +45.5% |
| 2008 | 20.0% | +25.0% |
| 2009 | 26.0% | +30.0% |
| 2010 | 34.0% | +30.8% |
| 2011 | 40.0% | +17.6% |
| 2012 | 45.0% | +12.5% |
| 2013 | 47.0% | +4.4% |
| 2014 | 52.0% | +10.6% |
| 2015 | 60.0% | +15.4% |
| 2016 | 65.0% | +8.3% |
| 2017 | 68.0% | +4.6% |
| 2018 | 71.0% | +4.4% |
| 2019 | 72.0% | +1.4% |
| 2020 | 71.0% | -1.4% |
| 2021 | 70.0% | -1.4% |
| 2022 | 69.0% | -1.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.3% | 2.0% | 26.0% | 10 |
| 2010s | 55.4% | 34.0% | 72.0% | 10 |
| 2020s | 70.0% | 69.0% | 71.0% | 3 |
Countries ranked near Estonia
More health data for Estonia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.02 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,416 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3 deaths (2100)
- Population ages 60-64, female, annual growth rate -1.83 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.034 units per person (2025)
- Population ages 60-64, male, annual growth rate -0.8794 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0294 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Estonia?
- Share of people with hiv who receive antiretroviral therapy in Estonia was 69.0% in 2022, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Estonia?
- The highest recorded value was 72.0% in 2019.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Estonia?
- The lowest recorded value was 2.0% in 2002.
- How does Estonia rank for share of people with hiv who receive antiretroviral therapy?
- Estonia ranks 78th out of 143 countries with data for 2022.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Estonia?
- Over the last ten years it is up 53.3%. The long-run trend across the full record is volatile.
- Where does this Estonia data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.